-- 
India Equity Movers: Crompton, GVK Power, Phoenix Mills, Ranbaxy

-- B y   A m e y a   K a r v e
-- 
2011-04-29T05:12:15Z

-- http://www.bloomberg.com/news/2011-04-29/india-equity-movers-crompton-gvk-power-phoenix-mills-ranbaxy.html
The following companies had unusual
price changes in India trading. Stock symbols are in parentheses
and share prices are as of 10:27 a.m. in Mumbai, unless stated
otherwise.  The Bombay Stock Exchange’s Sensitive Index, or Sensex,
fell 58.69, or 0.3 percent, to 19,233.33. The BSE 200 Index
retreated 0.2 percent to 2,377.46.  Bank of Baroda (BOB)   fell 1.3 percent to 929.85 rupees,
poised for its lowest closing price in more than a month. The
lender was cut to “neutral” from “overweight” by Adarsh Parasrampuria, an analyst at  JPMorgan Chase & Co. (JPM) , with a 12-
month estimate of 1,000 rupees per share.  Crompton Greaves Ltd. (CRG)   slumped 11 percent to 249
rupees, the steepest intraday fall in more than three months.
The electrical equipment maker’s net income for the three months
ended March 31 fell 18 percent to 2.51 billion rupees, according
to an exchange filing.  GVK Power & Infrastructure Ltd. (GVKP)   advanced 2.1
percent to 24.65 rupees. The infrastructure company is the
preferred bidder for the assets of Gina Rinehart’s Hancock Coal
in Queensland state’s Galilee Basin, the Australian Financial
Review reported in its Street Talk column, without saying where
it go the information. GVK, with a market value of A$1 billion,
faces costs of about A$2 billion to buy the assets and as much
as A$8 billion to develop infrastructure, according to the
report.  GVK spokesman Manish Kalghatgi couldn’t be reached for a
comment on the report.  Manappuram General Finance & Leasing Ltd. (MGFL)   rose
4.1 percent to 137 rupees, set for its lowest closing price
since Jan. 24. The provider of loans against gold said profit
for the year ended March 31 more than doubled to 2.83 billion
rupees and it will give one free share for each held, according
to an exchange filing.  Phoenix Mills Ltd. (PHNX)  , an Indian real estate
developer, surged 5.1 percent to 210.25 rupees, headed for its
highest closing level in more than three months. The company’s
fourth-quarter net income rose 61 percent to 272 million rupees,
according to a statement on the Bombay Stock Exchange.  Ranbaxy Laboratories Ltd. (RBXY)   added 1.8 percent to
461.7 rupees. The biggest Indian drugmaker by revenue and the
U.S.  Food and Drug Administration  urged a federal judge to
dismiss a lawsuit filed by Mylan Inc. that challenges whether
only the local company can begin selling copies of the
cholesterol pill Lipitor later this year.  -- Editor: Ravil Shirodkar  To contact the reporter on this story:
Ameya Karve in Mumbai at 
 akarve@bloomberg.net ;  To contact the editor responsible for this story:
Darren Boey at 
 dboey@bloomberg.net  